Activaero GmbH We are the world leader in the development of controlled breathing drug delivery technologies that maximize the efficiency and precision of inhaled drugs. Our innovative technologies enable safer, more cost-efficient and effective options for inhaled treatments of respiratory diseases. We are dedicated to improving the quality of life for patients with pulmonary diseases. We are developing, manufacturing and selling high quality inhalation systems for the treatment of severe lung diseases. As a center of excellence in aerosol medicine, we support pharma and biotech partners with consultation, technology and services in their pre-clinical and clinical projects for pulmonary drug development. The company goal for future is to deliver well-known medications to the lungs using our inhalation technology in own clinical programs and in turn, develop and market new therapeutic advances.